decitabine

decitabine
Trade Name Dacogen
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2006-08-04 00:00:00
Sponsor Otsuka Pharmaceutical Development &;Commercialization, Inc., 508 Carnegie Center Drive;Princeton, New Jersey, 08540
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia